📖

hypotheses-apoe-contributes-alzheimers-disease-regulat

wiki page Created: 2026-04-06T11:31:34 By: crosslink-v2 Quality: 50% ✓ SciDEX ID: wiki-hypotheses-apoe-contributes-alzheim

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

685

Outgoing

320

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (764)

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy90%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy90%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer90%

mentions🧪APOE Isoform Expression Across Glial Subtypes90%

mentions🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho90%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones90%

mentions🧪APOE Isoform Conversion Therapy90%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction90%

mentions🧫APOE4 association with TDP-43 pathology in AD90%

mentions🧪Competitive APOE4 Domain Stabilization Peptides90%

mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 90%

mentions🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho80%

mentions🧫APOE4 association with TDP-43 pathology in AD80%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau80%

mentions🧫GWAS of plasma pTau181 in East Asian cohort80%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection80%

see_also📖APOE4 (Apolipoprotein E4)80%

mentions🧫GWAS of plasma pTau217 in East Asian cohort80%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model80%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%

mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 80%

mentions🧫GWAS of plasma GFAP in East Asian cohort80%

mentions🧫GWAS of plasma NfL in East Asian cohort80%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE80%

mentions🧫GWAS of composite biomarker score80%

mentions🔬Analysis question not specified75%

mentions🔬Lipid metabolism dysregulation and membrane integrity in Alz75%

see_also📖nct0550878975%

see_also📖UPenn Observational Research Repository (NCT04715399)75%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 75%

see_also📖remternetug-anti-amyloid-alzheimers75%

see_also📖Endocannabinoid System in Neurodegeneration70%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration70%

see_also📖Mitochondrial Fusion in Neurodegeneration70%

see_also📖Cholinergic System Dysfunction in Neurodegeneration70%

mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD70%

see_also📖Hippocampal Neurogenesis in Neurodegeneration70%

see_also🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

see_also📖Prognostic Biomarkers in Neurodegeneration70%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener70%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration70%

see_also📖China Neurodegeneration Epidemiology70%

see_also📖Therapeutic Targets in Neurodegeneration70%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration70%

see_also📖Familial vs Sporadic Neurodegeneration Comparison70%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)70%

see_also📖Neuropeptide Y Signaling in Neurodegeneration70%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration70%

mentions🧪APOE Isoform Expression Across Glial Subtypes70%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration70%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio70%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration70%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison70%

see_also📖Synaptic Biomarkers in Neurodegeneration70%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)70%

see_also📖Paraptosis in Neurodegeneration70%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen70%

see_also📖Paranodal Dysfunction in Neurodegeneration70%

see_also📖Neural Circuit Disruption in Neurodegeneration70%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration70%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration70%

see_also📖NF-kB Signaling Pathway in Neurodegeneration70%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration70%

see_also🧪APOE Isoform Conversion Therapy70%

see_also📖RAN Translation in Neurodegeneration70%

see_also📖mTOR Signaling in Neurodegeneration70%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%

see_also📖Neuronal Hyperexcitability in Neurodegeneration70%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%

see_also📖Antibody Therapy in Neurodegeneration70%

see_also📖Autosis Pathway in Neurodegeneration70%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration70%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration70%

see_also📖Digital Phenotyping in Neurodegeneration70%

see_also📖HMGB1 Signaling in Neurodegeneration70%

mentions🧫Genetic Risk Modifiers in DLB Phenotype70%

see_also📖Prion Protein Metabolism in Neurodegeneration70%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su70%

see_also📖Economic Burden — Neurodegeneration70%

see_also📖Metal Homeostasis in Neurodegeneration70%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration70%

see_also🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

see_also📖Galectin-3 Mechanism in Neurodegeneration70%

mentions🧫DDT/DDE exposure and cognitive function in Latina women70%

see_also📖European Neurodegeneration Epidemiology70%

see_also📖DALY Methodology — Neurodegeneration70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

see_also🧪Competitive APOE4 Domain Stabilization Peptides70%

see_also📖Copper Homeostasis in Neurodegeneration70%

see_also📖Progesterone Signaling Pathway in Neurodegeneration70%

see_also📖Global Neurodegeneration Epidemiology70%

see_also📖Liquid Biopsy in Neurodegeneration70%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration70%

see_also📖Molecular Chaperones in Neurodegeneration70%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)70%

mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration70%

see_also📖Serotonergic Dysfunction in Neurodegeneration70%

see_also📖Prion Diseases in Neurodegeneration70%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio70%

see_also📖interleukin-6-signaling-neurodegeneration70%

see_also📖Exosomal Biomarkers in Neurodegeneration70%

see_also📖Vagus Nerve Pathway in Neurodegeneration70%

mentions🧫ApoE4 Function in Alzheimer's Disease70%

see_also📖Computational Disease Models for Neurodegeneration70%

see_also📖Integrated Stress Response in Neurodegeneration70%

see_also🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration70%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration70%

mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%

see_also📖SUMOylation in Neurodegeneration70%

see_also📖mTOR Signaling Pathway in Neurodegeneration70%

see_also📖Metabolomic Biomarkers in Neurodegeneration70%

mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol70%

see_also📖Senescent Cell Clearance in Neurodegeneration70%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy70%

see_also🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%

mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%

see_also📖Axon Guidance Pathways in Neurodegeneration70%

see_also📖Neuroimaging Biomarkers for Neurodegeneration70%

see_also📖Protein Aggregation Comparison in Neurodegeneration70%

see_also📖Nitric Oxide Signaling in Neurodegeneration70%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration70%

see_also📖Neuropil Threads in Neurodegeneration70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration70%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 70%

see_also📖R-Loop Stress in Neurodegeneration70%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration70%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration70%

mentions🧫Viral Infections and Alzheimer's Disease — causal mecha70%

see_also📖RNA Splicing in Neurodegeneration70%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration70%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration70%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration70%

see_also📖T-Cell Dysfunction in Neurodegeneration70%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration70%

see_also📖Endothelin Signaling Pathway in Neurodegeneration70%

mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%

see_also📖Dystrophic Neurites in Neurodegeneration70%

see_also📖Sleep Dysfunction in Neurodegeneration70%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739270%

see_also📖PKR Pathway in Neurodegeneration70%

see_also📖Retinal Degeneration Pathway in Neurodegeneration70%

mentions🧪Competitive APOE4 Domain Stabilization Peptides70%

see_also📖US Neurodegeneration Epidemiology70%

see_also📖Neural Circuits in Neurodegeneration70%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration70%

mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%

mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%

see_also📖Gangliosides in Neurodegeneration70%

see_also📖COVID-19 Neurodegeneration Mechanism70%

see_also📖Prion-Like Spread in Neurodegeneration70%

mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration70%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

see_also📖GDNF Signaling Pathway in Neurodegeneration70%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration70%

see_also📖epigenetics-neurodegeneration70%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration70%

see_also📖Manganese-Related Neurodegeneration (Manganism)70%

see_also🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

see_also📖acetylcholine-signaling-neurodegeneration70%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration70%

mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%

see_also📖Diffusion MRI (DTI) in Neurodegeneration70%

see_also📖Potential Impact Measures — Neurodegeneration70%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl70%

see_also📖MicroRNA Dysfunction in Neurodegeneration70%

see_also📖RNA-Targeted Therapies in Neurodegeneration70%

see_also📖Pericyte Loss in Neurodegeneration70%

see_also📖Kidney-Brain Neurodegeneration Axis70%

see_also📖IL-1 Signaling Pathway in Neurodegeneration70%

see_also📖CaMKII Signaling Pathway in Neurodegeneration70%

see_also📖Histone Modification Pathways in Neurodegeneration70%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)70%

see_also🧪APOE Isoform Expression Across Glial Subtypes70%

see_also📖Advanced Glycation End Products in Neurodegeneration70%

see_also📖APOE2 (Apolipoprotein E2)70%

see_also📖Sleep Disorders in Neurodegeneration70%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat70%

see_also📖Microglial Priming Pathway in Neurodegeneration70%

see_also📖APOE3 (Apolipoprotein E3)70%

see_also📖India Neurodegeneration Epidemiology70%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration70%

see_also🧪APOE4-Selective Lipid Nanoemulsion Therapy70%

see_also📖Parthanatos in Neurodegeneration70%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration70%

see_also📖Purinergic Signaling in Neurodegeneration70%

see_also📖Disease Progression & Staging in Neurodegeneration70%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration70%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration70%

see_also📖synaptic-vesicle-cycling-neurodegeneration70%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)70%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 70%

see_also📖Endosomal Sorting Defects in Neurodegeneration70%

see_also📖FA2H-Associated Neurodegeneration Pathway70%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread70%

see_also📖Down Syndrome Neurodegeneration Pathway70%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a70%

see_also📖Amylin Signaling in Neurodegeneration70%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 70%

see_also📖Glycosylation in Neurodegeneration70%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati70%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration70%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration70%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration70%

see_also📖Japan Neurodegeneration Epidemiology70%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%

mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%

see_also📖Short Chain Fatty Acids in Neurodegeneration70%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration70%

see_also📖NRF2 Signaling Pathway in Neurodegeneration70%

see_also📖Orexin Signaling in Neurodegeneration70%

see_also📖Protein Aggregation Seeds in Neurodegeneration70%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration70%

see_also📖Lipid Dysregulation in Neurodegeneration70%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 70%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration70%

see_also📖Neurotensin Signaling in Neurodegeneration70%

see_also📖Exosomal miR-155 in Neurodegeneration70%

see_also📖Ribosome Dysfunction in Neurodegeneration70%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration70%

see_also📖Convergent Pathways in Neurodegeneration70%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N70%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration70%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr70%

mentions🧪APOE Isoform Conversion Therapy70%

see_also📖Sex Differences in Neurodegeneration70%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain70%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%

mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati70%

see_also📖PPAR Signaling Pathway in Neurodegeneration70%

related🔬Analysis question not specified67%

see_also📖IL9 (Interleukin 9)60%

see_also📖DNAJB1 Gene60%

see_also📖Neumora Therapeutics60%

see_also📖DAXX Gene60%

see_also📖DLG2 Gene60%

see_also📖C3 — Complement Component 360%

see_also📖ZCWPW1 — Zinc Finger CW-Type and PWWP Domain60%

see_also📖MSH3 Gene60%

see_also📖Chelsea Therapeutics60%

see_also📖LPL — Lipoprotein Lipase60%

see_also📖Cytochrome Therapeutics60%

see_also📖cyclo-therapeutics60%

see_also📖lecanemab60%

see_also📖GJA1 Protein60%

see_also📖DUSP10 Gene60%

see_also📖4D Molecular Therapeutics60%

see_also📖Reactive Oxygen Species (ROS)60%

see_also📖CD38 Molecule (CD38)60%

see_also📖NEFL — Neurofilament Light Chain60%

see_also📖icam160%

see_also📖ATP13A2 — ATPase Cation Transporting 13A260%

see_also📖IRAK4 Gene60%

see_also📖Cathepsin S Protein60%

see_also📖VAMP2 Gene - Synaptobrevin-260%

see_also📖GSTP1 — Glutathione S-Transferase Pi 160%

see_also📖APLP1 Gene60%

see_also📖PEN2 Protein60%

see_also📖PSD-95 (Postsynaptic Density Protein 95)60%

see_also📖NOTCH1 Gene60%

related🧪APOE Isoform Conversion Therapy60%

see_also📖PEN2 Protein60%

see_also📖Lyterian Therapeutics60%

see_also📖calcium-dysregulation-alzheimers60%

see_also📖IFM Therapeutics60%

see_also📖Parkinson's Disease Digital Therapeutics Companies60%

see_also📖Clusterin (ApoJ) - AD Biomarker60%

see_also📖P4HB Gene60%

see_also📖ST6GALNAC5 Gene60%

see_also📖Clusterin (CLU / Apolipoprotein J)60%

see_also📖CLEC7A Gene60%

see_also📖MAPK10 Gene60%

see_also📖ERCC2 Gene - Excision Repair Cross-Complementation Group 260%

see_also📖AD RNA-Based Therapeutics Companies60%

see_also📖Convelo Therapeutics60%

see_also📖ANG — Angiogenin60%

see_also📖VTV Therapeutics60%

see_also📖MDH1 — Malate Dehydrogenase 160%

see_also📖MMP1 - Matrix Metallopeptidase 160%

see_also📖EED60%

see_also📖RPS23 — Ribosomal Protein S2360%

see_also📖Appvian Therapeutics60%

see_also📖PRDX3 — Peroxiredoxin 360%

see_also📖AD Exosome and Extracellular Vesicle Companies60%

see_also📖DHCR24 Gene60%

see_also📖GSTP1 Protein (Glutathione S-Transferase Pi 1)60%

see_also📖MDM2 Gene60%

see_also📖Spark Therapeutics60%

see_also📖SLC1A2 — Solute Carrier Family 1 Member 2 (EAAT2)60%

see_also📖Monte Rosa Therapeutics60%

see_also📖DLK — Dual Leucine Zipper Kinase60%

see_also📖GLP-1 Receptor Agonist Therapeutics Investment Landscape60%

see_also📖Calcium-Dysregulated Neurons60%

see_also📖SERPINA3 Gene — Alpha-1 Antichymotrypsin in Neurodegeneratio60%

see_also📖FERMT2 Protein60%

see_also📖NPTX1 — Neuronal Pentraxin 160%

see_also📖Progranulin (PGRN)60%

see_also📖GCH1 Gene60%

see_also📖TRIM24 — Tripartite Motif Containing 2460%

see_also📖Calcium Dysregulation in Progressive Supranuclear Palsy60%

see_also📖IDE Gene - Insulin-Degrading Enzyme60%

see_also📖CXCL160%

see_also📖VAMP2 Protein60%

see_also📖NUCKS1 Gene60%

see_also📖Calcium Dysregulation in Alzheimer's Disease60%

see_also📖Heat Shock Protein (HSP) Therapeutics for Neurodegeneration60%

see_also📖TLR9 — Toll-Like Receptor 960%

see_also📖Sangamo Therapeutics60%

see_also📖LRP6 Gene60%

see_also📖VGF Nerve Growth Factor60%

see_also📖calcium-buffering-proteins-neurodegeneration60%

see_also📖USH2A Protein60%

see_also📖SMPD1 Gene - Acid Sphingomyelinase60%

see_also📖Calcium Signaling — Investment Landscape Analysis60%

see_also📖calcium-dysregulation-comparison60%

see_also📖RELB Gene60%

see_also📖NeuExo Therapeutics60%

see_also📖SHARPIN — SHANK Associated RH Domain Interactor60%

see_also📖ULK2 Gene60%

see_also📖a2m60%

see_also📖pecam160%

see_also📖C5 Protein60%

see_also📖RPS6KB1 Gene60%

see_also📖LIPA Gene60%

see_also📖NPTX1 Protein60%

see_also📖CASS4 — Cas Scaffold Protein Family Member 460%

see_also📖Calcium Homeostasis in Neurons60%

see_also📖Encoded Therapeutics60%

see_also📖pon160%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 60%

see_also📖CFB — Complement Factor B60%

see_also📖TOMM40 Gene60%

see_also📖SORT1 Gene60%

see_also📖Anti-Amyloid Therapeutics: Successes, Failures, and Lessons 60%

see_also📖calcium-dysregulation60%

see_also📖gab260%

see_also📖Arvinas Therapeutics60%

see_also📖Digital Therapeutics for Neurodegenerative Diseases60%

see_also📖SLC6A3 Gene60%

see_also📖Voyager Therapeutics60%

see_also📖Progranulin (PGRN) - Biomarker60%

see_also📖Gene Therapy for Neurodegenerative Diseases60%

see_also📖Calcium Dysregulation-Vulnerable Neurons60%

see_also📖CCR660%

see_also📖HDAC9 Gene60%

see_also📖sod360%

see_also📖NPC2 — NPC Intracellular Cholesterol Transporter 260%

see_also📖MYT1L Gene60%

see_also📖Calcium Dysregulation in Neurodegenerative Diseases60%

see_also📖REST Gene60%

see_also📖Alterity Therapeutics60%

see_also📖CHRNE Gene60%

see_also📖Calcium-Binding Protein Neurons60%

see_also📖Sepiapterin Reductase (SPR)60%

see_also📖siRNA and RNA Therapeutics Brain Delivery60%

see_also📖Reactive Oxygen Species (ROS)60%

see_also📖Calcium Dysregulation in Corticobasal Syndrome60%

see_also📖max60%

see_also📖EPHB4 Gene60%

see_also📖ctsl60%

see_also📖Extracellular Matrix in Neurodegeneration60%

see_also📖CELF1 Gene60%

see_also📖FERMT2 Gene60%

see_also📖LRP1060%

see_also📖Gene Therapy for Neurodegenerative Diseases60%

see_also📖RELN Gene60%

see_also📖Adult Neurogenesis Therapeutics Investment Landscape60%

see_also📖SMARCB1 — SWI/SNF Related Matrix Associated Actin Dependent 60%

see_also📖Prevail Therapeutics60%

see_also📖Gene Therapy for Neurodegenerative Diseases60%

see_also📖Evox Therapeutics60%

see_also📖ER Stress & UPR Therapeutics Investment Landscape60%

see_also📖Reelin Protein60%

see_also📖Mitochondrial Therapeutics60%

see_also📖Disease-Associated Microglia (DAM)60%

see_also📖PEN2 Gene60%

see_also📖Inception Therapeutics60%

see_also📖CD163 (Hemoglobin Scavenger Receptor)60%

see_also📖VEGFB Gene60%

see_also📖Mu-Opioid Receptor Protein60%

see_also📖heqIX Therapeutics60%

see_also📖SPR Gene60%

see_also📖stxbp360%

see_also📖NOS1 — Nitric Oxide Synthase 160%

see_also📖IGF2R Protein60%

see_also📖slc30a860%

see_also📖PLP1 Protein60%

see_also📖Alzheimer's Digital Therapeutics Companies60%

see_also📖Calcium Channel Dysfunction in Parkinson's Disease60%

see_also📖Denali Therapeutics60%

see_also📖Muna Therapeutics60%

see_also📖MAP2 Gene60%

see_also📖Ventus Therapeutics60%

see_also📖Calcium Homeostasis in Neurodegeneration60%

see_also📖TRAF6 Protein60%

see_also📖adam1760%

see_also📖LRP5 — Low Density Lipoprotein Receptor-Related Protein 560%

see_also📖Calcium Dysregulation in 4R-Tauopathies — Cross-Disease Comp60%

see_also📖SLC6A2 — Norepinephrine Transporter60%

see_also📖Exosome-Based Therapeutics for Neurodegenerative Diseases60%

see_also📖Aleza Therapeutics60%

see_also📖Yumanity Therapeutics60%

see_also📖Neteo Therapeutics60%

see_also📖RPL24 — Ribosomal Protein L2460%

see_also📖4R Tauopathy Therapeutics — Investment Landscape Analysis60%

see_also📖Ferroportin (SLC40A1)60%

see_also📖siRNA Therapy for Parkinson's Disease60%

see_also📖ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 460%

see_also📖Pinteon Therapeutics60%

see_also📖Calcium Signaling Dysregulation in Parkinson's Disease60%

see_also📖IRF7 Gene60%

see_also📖Rodin Therapeutics60%

see_also📖Neuroprotection Strategies in Neurodegeneration60%

see_also📖Pear Therapeutics60%

see_also📖SIGLEC1 Gene60%

see_also📖PLP1 Gene60%

see_also📖CRYAB Gene60%

see_also📖Neurotrophic Factor Therapies for Neurodegenerative Diseases60%

see_also📖UNC5B — Netrin-1 Receptor60%

see_also📖RNA Therapeutics: Investment Landscape Analysis60%

see_also📖adam1060%

see_also📖Lexeo Therapeutics60%

see_also📖ERLIN2 — ER Lipid Raft Associated 260%

see_also📖CALM1 — Calmodulin 160%

see_also📖C1QB — Complement Component 1Q Beta60%

see_also📖MT1A (Metallothionein-1A)60%

see_also📖CXCR4 Gene60%

see_also📖Cerevel Therapeutics60%

see_also📖Gene Therapy for Neurodegeneration60%

see_also📖KIF13A Gene60%

see_also📖Lipophagy Activation Therapy for Neurodegeneration60%

see_also📖PLIN2 Gene60%

see_also📖slc22a160%

see_also📖Dynein — Cytoplasmic Dynein 160%

see_also📖Anti-Amyloid Therapeutics60%

see_also📖CD44 - Cell Surface Glycoprotein60%

see_also📖EPHA1 Gene60%

see_also📖Lecanemab CLARITY Open-Label Extension60%

see_also📖DAPK1 Gene60%

see_also📖alzheimers-disease60%

see_also📖TRAIL Gene (TNFSF10)60%

see_also📖NCSTN Gene - Nicastrin60%

see_also📖T3D Therapeutics60%

see_also📖CREB1 Gene60%

see_also📖DAB1 Gene60%

see_also📖Calcium Signaling Dysregulation in Alzheimer's Disease60%

see_also📖RXRA60%

see_also📖HTRA1 Gene60%

see_also📖SPP1 Gene60%

see_also📖CFH60%

see_also📖Synaptic Therapeutics60%

see_also📖Anti-Tau Therapeutics: Investment Landscape Analysis60%

see_also📖cct460%

see_also📖KMT2D — Lysine Methyltransferase 2D60%

see_also📖Peptide Therapeutics for Neurodegeneration — Investment Land60%

see_also📖Calcium Dysregulation in Neurodegeneration60%

see_also📖Extracellular Matrix and Perineuronal Nets in 4R-Tauopathies60%

see_also📖GABRA1 Gene60%

see_also📖Mitochondrial Therapeutics Investment Landscape60%

see_also📖RNF14 — Ring Finger Protein 1460%

see_also📖Iduna Therapeutics60%

see_also📖Click Therapeutics60%

see_also📖Spin Therapeutics60%

see_also📖NCSTN Protein60%

see_also📖Calcium Dysregulation to Excitotoxicity Pathway60%

see_also📖Aleza Therapeutics60%

see_also📖ABI3 Gene60%

see_also📖Axial Therapeutics60%

see_also📖slc17a7 Gene60%

see_also📖MS4A4E Gene - Membrane-Spanning 4-Domains A4E60%

see_also📖ANO3 Gene60%

see_also📖CLDN5 — Claudin-560%

see_also📖NME8 Gene60%

see_also📖NeuBase Therapeutics60%

see_also📖STX6 Gene60%

see_also📖Koneqia Therapeutics60%

see_also📖MRC1 — Mannose Receptor C Type 160%

see_also📖ADRB2 Gene60%

see_also📖calb160%

see_also📖Calcium Homeostasis Modulation Therapy for Neurodegeneration60%

see_also📖NeuroMito Therapeutics60%

see_also📖prdx660%

see_also📖IL13 — Interleukin 1360%

see_also📖IFNAR1 — Interferon Alpha Receptor 160%

see_also📖CHIT1 Gene (Chitinase 1)60%

see_also📖slc44a260%

see_also📖ABCA2 Gene - ATP Binding Cassette Subfamily A Member 260%

see_also📖Dynein Motor Protein60%

see_also📖therapeutics60%

see_also📖Ferroportin60%

see_also📖MAP2 Protein — Microtubule-Associated Protein 260%

see_also📖HTR2C Gene60%

see_also📖JAK1 — Janus Kinase 160%

see_also📖TRAF6 Gene60%

see_also📖Sage Therapeutics60%

see_also📖Lipophagy Pathway in Neurodegeneration60%

see_also📖ADRA2A Gene60%

see_also📖Senolytic Therapeutics: Investment Landscape Analysis60%

see_also📖CD6360%

see_also📖NDUFAF7 Gene60%

see_also📖SSBP1 Gene60%

see_also📖SEMA3F Gene60%

see_also📖LILRB2 — Leukocyte Immunoglobulin-Like Receptor B260%

see_also📖Lecanemab CLARITY-AD Trial60%

see_also📖BrainStorm Cell Therapeutics Inc.60%

see_also📖VPS35 — Vacuolar Protein Sorting 35 Homolog60%

see_also📖CRISPR Therapeutics60%

see_also📖Calcium Homeostasis Modulators in Neurodegeneration60%

see_also📖Presenilin Enhancer 2 (PEN-2) Protein60%

see_also📖TGF-beta Signaling Therapies for Neurodegeneration60%

see_also📖BlueRock Therapeutics60%

see_also📖CTSH Gene60%

see_also📖CHI3L1 Gene60%

see_also📖calcium-dysregulation-pd60%

see_also📖Protein Aggregation Inhibitors for Neurodegeneration — Inves60%

see_also📖TMEM59 Gene60%

see_also📖VDAC1 — Voltage Dependent Anion Channel 160%

see_also📖Calcium Signaling Dysregulation - Investment Landscape60%

see_also📖MAX Protein (MAX)60%

see_also📖Gene Therapy for Neurodegeneration60%

see_also📖Notch1 Protein60%

see_also📖Lysoway Therapeutics60%

see_also📖PITX3 Gene60%

see_also📖LRP5 Protein60%

see_also📖Paxos Therapeutics60%

see_also📖Vator Therapeutics Inc.60%

see_also📖Stoke Therapeutics60%

see_also📖MS4A6A Gene60%

see_also📖FGF19 — Fibroblast Growth Factor 1960%

see_also📖Anti-Tau Therapeutics60%

see_also📖IRAK4 Protein60%

see_also📖il17a60%

see_also📖Update TDP-43 protein page with comprehensive content60%

see_also📖LRP8 Gene60%

see_also📖TDP-43 (TAR DNA-Binding Protein 43) - Biomarker60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖SYNE2 Gene60%

see_also📖Extracellular Matrix and Integrin Modulator Therapy for Neur60%

see_also📖Capricor Therapeutics60%

see_also📖SNCAIP Gene60%

see_also📖Lysosomal Dysfunction Therapeutics Investment Landscape60%

see_also📖Synchronicity Therapeutics60%

see_also📖ATP13A2 Protein (PARK9)60%

see_also📖MAOB Gene60%

see_also📖Resveratrol and Sirtuin Activation for Neurodegeneration60%

see_also📖MAP1S - Microtubule Associated Protein 1S60%

see_also📖Calcium Signaling Pathway in Neurodegeneration60%

see_also📖Neurodegeneration60%

see_also📖PIK3R1 Gene60%

see_also📖COMT Gene60%

see_also📖CFOS Gene60%

see_also📖Trefoil Therapeutics60%

see_also📖VPS35 Protein60%

see_also📖Finch Therapeutics60%

see_also📖nbea60%

see_also📖CLU Gene - Clusterin60%

see_also📖St6galnac5 (ST6 N-acetylneuraminic acid alpha-2,6-sialyltran60%

see_also📖OPRM1 — Mu-Opioid Receptor60%

see_also📖SYK Gene60%

see_also📖GJA160%

see_also📖NF-κB RelB Protein60%

see_also📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease60%

see_also📖CD960%

see_also📖Amyl Therapeutics60%

see_also📖PSAP Gene - Prosaposin60%

see_also📖DMPK Gene (Dystrophia Myotonica Protein Kinase)60%

see_also📖Denali Therapeutics60%

see_also📖Calcium Signaling Dysregulation in Neurodegeneration60%

see_also📖Calcium Signaling Dysregulation in Alzheimer's Disease60%

see_also📖CASS4 Protein60%

see_also📖BCHE Gene - Butyrylcholinesterase60%

see_also📖Clusterin Protein60%

see_also📖BCL2L1 Gene60%

see_also📖cxcr460%

see_also📖IRAK4 Kinase Modulation Therapy for Neurodegeneration60%

see_also📖nrp160%

see_also📖TRAF6 Protein60%

see_also📖PIN1 — Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 60%

see_also📖PD RNA Therapeutics Companies60%

see_also📖C560%

see_also📖Alectos Therapeutics Inc60%

see_also📖Fulcrum Therapeutics60%

see_also📖ALDH2 — Aldehyde Dehydrogenase 260%

see_also📖SLC6A4 Gene — Serotonin Transporter60%

see_also📖C1QC60%

see_also📖SFPQ Gene60%

see_also📖ANG Protein60%

see_also📖vglut160%

see_also📖CTSF Gene (CLN10)60%

see_also📖Mitch A. Max60%

see_also📖Lecanemab (Leqembi)60%

see_also📖EIF2AK2 — Eukaryotic Translation Initiation Factor 2 Alpha K60%

see_also📖Calcium Channel Blockers in Neurodegeneration60%

see_also📖Denali Therapeutics60%

see_also📖Microbiome-Based Therapeutics for Neurodegeneration: Investm60%

see_also📖TNF Gene60%

see_also📖Neuronal Nitric Oxide Synthase60%

see_also📖VGF — VGF Nerve Growth Factor Inducible60%

see_also📖RNA Editing Therapeutics60%

see_also📖MSH3 (Redirect)60%

see_also📖IL4 Gene60%

see_also📖cynata-therapeutics60%

see_also📖USH2A Gene60%

see_also📖Karuna Therapeutics60%

see_also📖ids60%

see_also📖pd-exosome-therapeutics60%

see_also📖VGLUT1 Protein60%

see_also📖Calcium Channel Dysfunction in Neurodegeneration60%

see_also📖APH1B Gene - Anterior Pharynx Defective 1 Homolog B60%

see_also📖Axsome Therapeutics, Inc.60%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime55%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh55%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di55%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717050%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)50%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial50%

mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim50%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

see_also📖UB-311 Alzheimer's Vaccination Trial50%

mentions🧪Membrane Cholesterol Gradient Modulators50%

mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

see_also📖al002-trem2-agonist-alzheimers50%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%

mentions🧫Microglial TREM2 Agonist In Vivo Efficacy50%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI50%

mentions🧫Multi-omics analysis of myricanol effects on gene expression50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451650%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%

see_also📖Alzheimer's Disease Mechanism Index45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%

mentions🧫Anti-Tau Immunotherapy Dosing Optimization44%

mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo44%

mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro44%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP44%

related🧪Complement C1q Subtype Switching40%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%

related🧪PARP1 Inhibition Therapy40%

hypotheses-apoe-contributes-alzheimers-disease-regulat

💬 Discussion